Jamison Private Wealth Management’s ResMed RMD Stock Holding History

Jamison Private Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5	Closed	-$991	–	517
2024 Q1	$991	Buy	+5	New	+$916	﹤0.01%	426

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jamison Private Wealth Management's RMD Position: Q2 2024 in Review

Jamison Private Wealth Management sold out of ResMed (RMD) in Q2 2024, closing a stake of 5 shares — an estimated $991 sold.

Jamison Private Wealth Management first reported a position in RMD in Q1 2024 and held it in 1 quarter. The position peaked at $991 in Q1 2024. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

Jamison Private Wealth Management reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
Jamison Private Wealth Management sold 5 ResMed shares in Q2 2024, an estimated $991.
Jamison Private Wealth Management first reported a position in ResMed in Q1 2024 and held it in 1 quarter.
Jamison Private Wealth Management's ResMed position peaked at $991 in Q1 2024.
771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Jamison Private Wealth Management's 13F filing for Q2 2024, filed 11 Jul 2024.